Skip to main content
. 2024 May 22;7:49. doi: 10.1186/s42155-024-00463-5

Table 1.

Patient characteristics

Transjugular approach ( n =10) Transfemoral approach ( n =13) p -value
Age (y) 63.1 ± 14.2 59.6 ± 9.3 0.3
Male gender (n) 7 (70%) 9 (69%) 1
Tumor type (n) 0.65
 Metastases 7 (70%) 9 (69%)
 Cholangiocarcinoma 3 (30%) 3 (23%)
 Hepatocellular carcinoma 0 (0%) 1 (8%)
Cirrhosis (n) 0 (0%) 1 (8%) 1
Neoadjuvant chemotherapy (n) 6 (60%) 10 (77%) 0.65
Proposed type of surgery (n) 0.17
 Hemihepatectomy 3 (30%) 5 (38%)
 Hemihepatectomy + wedge resection 1 (10%) 5 (38%)
 Extended hemihepatectomy 4 (40%) 3 (23%)
 Extended hemihepatectomy + wedge resection 2 (20%) 0 (0%)